Improved RFS in Resected Melanoma with mRNA Vaccine/Pembrolizumab

Retrieved on: 2023-10-23 18:42:25

Tags for this article:

Breakthrough therapy

Orphan drugs

Circulating tumor DNA

Melanoma

Small-cell carcinoma

Click the tags to see associated articles and topics

Improved RFS in Resected Melanoma with mRNA Vaccine/Pembrolizumab. View article details on HISWAI: https://www.targetedonc.com/view/improved-rfs-in-resected-melanoma-with-mrna-vaccine-pembrolizumab

Excerpt

Combining the individualized neoantigen therapy mRNA-4157 (V940) with pembrolizumab (Keytruda) yielded clinically significant improvements in ...

Article found on: www.targetedonc.com

View Original Article